Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
JIMPosters
Author(s): Emily Mae L Yap , Alexander A Tuazon Added: 2 years ago

MI/ACS
JIMPosters
Author(s): Emily Mae L Yap , Christopher A Macaraeg , Richard Ayuson , et al Added: 2 years ago

MI/ACS

Intervention
Research Area(s) / Expertise:
Author(s): Stéphane G Carlier Added: 3 years ago
Cordis Corporation recently announced that it has received CE mark approval for the treatment of acute myocardial infarction (AMI) using the CYPHER® SELECT™ PLUS sirolimus-eluting coronary stent. CE marking means conformity to the applicable European Directive, and in the specific context of AMI permits the CYPHER stent to be placed on the market for treatment of AMI in all Member States of the… View more

MI/ACS

Intervention
Author(s): David S Wald , Jonathan P Bestwick Added: 3 years ago
The management of patients with acute ST-elevation myocardial infarction (STEMI) relies on restoring blood flow to the occluded infarct artery. Prompt percutaneous coronary intervention (PCI) and stenting of the stenosis causing the occlusion reduces the risk of cardiac death and recurrent infarction.1 In about half of patients,2 stenoses are identified in non-infarct arteries at the time of the… View more

Prevention & Chronic Conditions

MI/ACS
Author(s): Tim P van de Hoef , Werner Mohl , Ahmed A Khattab , et al Added: 3 years ago
Fast and effective opening of epicardial arteries by thrombolysis or percutaneous coronary intervention (PCI) to restore perfusion to the jeopardised myocardium is considered the cornerstone in the treatment of patients with an acute ST-elevation myocardial infarction (STEMI) leading to a reduction in morbidity and mortality.1 However, despite successful opening of the coronary artery, myocardial… View more

Intervention

MI/ACS
ESC 23: MULTISTARS AMI Trial
Author(s): Barbara Stähli Added: 7 months ago
ESC 2023 — Prof Barbara Stähli (University Hospital Zurich, CH) joins us onsite at ESC 23 to outline the findings of the MULTISTARS AMI Trial (NCT03135275). MULTISTARS AMI aimed to compare the safety and efficacy of two treatment strategies currently performed in clinical practice, immediate complete revascularization versus staged complete revascularization in patients presenting with ST… View more

MI/ACS

Intervention
Author(s): Fizzah A Choudry , Roshan P Weerackody , Daniel A Jones , et al Added: 3 years ago
Over the last few decades, primary percutaneous coronary intervention (PCI) has revolutionised the treatment of ST-elevation myocardial infarction (STEMI) with rapid recanalisation of the infarct-related epicardial vessel, resulting in smaller infarct size and a substantial reduction in adverse clinical endpoints.1,2 However, suboptimal myocardial reperfusion is documented to occur in a… View more

Intervention
Author(s): Deepak Natarajan Added: 3 years ago
Primary percutaneous coronary intervention (PCI) is the treatment of choice in the management of acute ST-segment elevation myocardial infarction (STEMI). It has been constantly observed that, despite restoring good epicardial flow with PCI, myocardial perfusion at the cellular level remains impaired in nearly 50 % of STEMI patients. This led to the development of a new class of antiplatelet… View more

Anticoagulation

MI/ACS
Incorporating Infarct Size into Trial Composite Endpoints: Implications for Unloading Trials
Author(s): James Udelson Added: 6 years ago

Prevention & Chronic Conditions